BARRY FELDMAN: Open Payments
NPI 1972588259 · FARMINGTON HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 24 payments from 9 companies in 2025. Trend: 2023 $471 · 2024 $313 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $175 |
| Medtronic, Inc. | 1 | $116 |
| Lilly USA, LLC | 3 | $51 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Dexcom, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $18 |
| ABIOMED | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Ozempic, CARDIOBLATE GEMINI, Rybelsus, Dexcom G6 Transmitter, JARDIANCE, EVENITY, KISUNLA, AREXVY.
Industry payments across MI — which companies pay providers there.
